封面
市場調查報告書
商品編碼
1596908

臨床營養市場規模、佔有率、成長分析、按管理途徑、按應用、按分銷管道、按最終用戶、按地區 - 行業預測,2024-2031年

Clinical Nutrition Market Size, Share, Growth Analysis, By Route of Administration (Oral, Parenteral) By Application (Cancer, Neurological Diseases), By Distribution Channel, By End User, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年全球臨床營養市場規模估值為356億美元,預計從2023年的387億美元成長到2031年的711億美元,預測期內(2024-2031年)年複合成長率為7.9%。

隨著糖尿病和發炎性腸道疾病疾病等文明病相關疾病的日益流行,凸顯了對客製化營養支持的需求,臨床營養市場預計將顯著成長。臨床營養著重於利用必需的維生素、礦物質和營養素來最佳化代謝系統,以改善患者的健康。其應用涵蓋心臟復健、腎臟透析、兒科營養、癌症支持、創傷復健和健康舉措等多個領域,凸顯了其在醫療保健領域的多功能性。人口老化和政府對醫療保健研發的投資將進一步支持市場擴張。此外,亞太和拉丁美洲等新興地區對臨床營養的需求不斷成長,以及家庭醫療保健解決方案的成長趨勢,使全球臨床營養市場在預測期內成為一個有吸引力的投資機會。隨著醫療保健的不斷發展,將臨床營養納入治療計劃和預防保健策略將在改善健康結果和滿足不同人群的營養需求方面發揮重要作用。

目錄

介紹

  • 研究目的
  • 調查範圍
  • 定義

調查方法

  • 資訊採購
  • 二手資料和主要資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 依細分市場的機會分析

市場動態及展望

  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素和機會
    • 抑制因素和挑戰
  • 波特分析與影響
    • 競爭公司之間的敵對關係
    • 替代品的威脅
    • 買方議價能力
    • 新進入者的威脅
    • 供應商的議價能力

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 監管環境
  • 專利分析
  • 價值鏈分析
  • PESTEL分析
  • 市場吸引力指數
  • 原料分析
  • 價格分析

臨床營養市場規模:依給藥途徑

  • 市場概況
  • 經口
  • 非經口
  • 經腸

臨床營養市場規模:依應用分類

  • 市場概況
  • 癌症
  • 神經系統疾病
  • 胃腸道疾病
  • 代謝紊亂
  • 其他

臨床營養市場規模:依通路分類

  • 市場概況
  • 線上
  • 離線
    • 零售店
    • 企業銷售管道
    • 其他

臨床營養市場規模:依最終用戶分類

  • 市場概況
  • 兒童
  • 成人
  • 老年人

臨床營養市場規模:依營養成分分類

  • 市場概況
  • 以蛋白質為基礎的營養
  • 富含維生素和礦物質的營養
  • 以碳水化合物為基礎的營養
  • 以脂肪為基礎的營養

臨床營養市場規模:依地區

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東、非洲

競爭資訊

  • 前5名企業比較
  • 主要企業市場定位(2023年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市場佔有率分析(2023年)
  • 主要企業簡介
    • 公司簡介
    • 產品系列分析
    • 依細分市場分類的佔有率分析
    • 收益與前一年同期比較(2021-2023)

主要企業簡介

  • Abbott Laboratories(US)
  • Nestle Health Science(Switzerland)
  • Danone Nutricia(France)
  • Fresenius Kabi(Germany)
  • Baxter International(US)
  • B. Braun Melsungen AG(Germany)
  • Mead Johnson Nutrition(Reckitt)(US)
  • GlaxoSmithKline(GSK)(UK)
  • Pfizer(US)
  • Ajinomoto Co., Inc.(Japan)
  • Koninklijke DSM NV(Netherlands)
  • Lonza Group(Switzerland)
  • Cambrooke Therapeutics(US)
  • Sichuan Kelun Pharmaceutical Co. Ltd.(China)
  • Otsuka Pharmaceutical(Japan)
  • Hormel Health Labs(US)
  • Perrigo Company(Ireland)
  • Hero Group(Switzerland)
  • Victus(US)
  • Entrocare Nutritional Solutions(UK)

結論和建議

簡介目錄
Product Code: SQMIG30A2012

Global Clinical Nutrition Market size was valued at USD 35.6 billion in 2022 and is poised to grow from USD 38.7 billion in 2023 to USD 71.1 billion by 2031, growing at a CAGR of 7.9% during the forecast period (2024-2031).

The clinical nutrition market is poised for significant growth, driven by the increasing prevalence of lifestyle-related diseases such as diabetes and inflammatory bowel disease, which highlight the need for tailored nutritional support. Clinical nutrition focuses on optimizing the metabolic system through essential vitamins, minerals, and nutrients aimed at enhancing patient health. Its applications span various sectors, including cardiac rehabilitation, renal dialysis, pediatric nutrition, cancer support, trauma recovery, and wellness initiatives, underpinning its versatility in healthcare. The aging population and substantial government investments in healthcare research and development further bolster market expansion. Additionally, the rising demand for clinical nutrition in emerging regions such as Asia-Pacific and Latin America, coupled with a growing trend towards home healthcare solutions, positions the global clinical nutrition market as an attractive investment opportunity during the forecast period. As healthcare continues to evolve, the integration of clinical nutrition into treatment plans and preventive care strategies will play a crucial role in improving health outcomes and addressing the nutritional needs of diverse populations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Nutrition Market Segmental Analysis

Global Clinical Nutrition Market is segmented by Route of Administration, application, Distribution Channel, end user, Nutritional Content and region. Based on Route of Administration, the market is segmented into Oral, Parenteral, and Enteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorder, Metabolic Disorder, and Others. Based on Distribution Channel, the market is segmented into Online and Offline. Based on end user, the market is segmented into Paediatric, Adults, and Geriatric. Based on By Nutritional Content, the market is segmented into Protein-Based Nutrition, Vitamin and Mineral-Rich Nutrition, Carbohydrate-Based Nutrition, and Fat-Based Nutrition. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Clinical Nutrition Market

The global clinical nutrition market is experiencing significant growth due to the increasing prevalence of lifestyle-related diseases and the rising elderly population. As individuals age, their activity levels diminish, metabolic rates decrease, and energy needs decline, leading to a deterioration in their ability to absorb and utilize essential nutrients. This decline amplifies their nutritional requirements, creating a heightened demand for clinical nutrition solutions that enhance energy absorption and utilization. Consequently, the growing emphasis on meeting the specific nutritional needs of older adults is poised to drive market expansion throughout the forecast period, reflecting a broader trend towards proactive health management.

Restraints in the Global Clinical Nutrition Market

The Global Clinical Nutrition market faces significant challenges, primarily due to a lack of awareness and the high costs associated with clinical nutrition products. Despite a rising demand for therapeutic nutritional solutions, both healthcare professionals and the general public remain largely uninformed about the benefits of clinical nutrition in both developed and developing nations. This limited understanding has contributed to widespread misinformation regarding vitamins and dietary practices, leading to nutritional deficiencies and related health issues. Consequently, the inadequate knowledge and appreciation of clinical nutrition serve as substantial barriers to market growth, hindering its expansion throughout the forecast period.

Market Trends of the Global Clinical Nutrition Market

The Global Clinical Nutrition market is witnessing significant growth fueled by enhanced healthcare infrastructure and a rising necessity for improved healthcare solutions, particularly in emerging regions like Asia-Pacific and LAMEA. This trend is further accelerated by the alarming rise in lifestyle-related chronic diseases that contribute to malnutrition and dietary complications. As healthcare demands evolve, there is an increased emphasis on research and development of specialized medical devices aimed at addressing diverse health issues, including respiratory, renal, and oncological conditions. Consequently, these factors are creating lucrative opportunities for expansion and innovation within the clinical nutrition sector.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Regulatory Landscape
  • Patent Analysis
  • Value Chain Analysis
  • PESTEL Analysis
  • Market Attractiveness Index
  • Raw Material Analysis
  • Pricing Analysis

Global Clinical Nutrition Market Size by Route of Administration & CAGR (2024-2031)

  • Market Overview
  • Oral
  • Parenteral
  • Enteral

Global Clinical Nutrition Market Size by Application & CAGR (2024-2031)

  • Market Overview
  • Cancer
  • Neurological Diseases
  • Gastrointestinal Disorder
  • Metabolic Disorder
  • Others

Global Clinical Nutrition Market Size by Distribution Channel & CAGR (2024-2031)

  • Market Overview
  • Online
  • Offline
    • Retail Stores
    • Institutional Sales Channel
    • Others

Global Clinical Nutrition Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Pediatrics
  • Adults
  • Geriatric

Global Clinical Nutrition Market Size by Nutritional Content & CAGR (2024-2031)

  • Market Overview
  • Protein-Based Nutrition
  • Vitamin and Mineral-Rich Nutrition
  • Carbohydrate-Based Nutrition
  • Fat-Based Nutrition

Global Clinical Nutrition Market Size & CAGR (2024-2031)

  • North America, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
    • US
    • Canada
  • Europe, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa, (By Route of Administration, By Application, By Distribution Channel, By End User, By Nutritional Content)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Abbott Laboratories (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nestle Health Science (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danone Nutricia (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Kabi (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mead Johnson Nutrition (Reckitt) (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline (GSK) (U.K.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ajinomoto Co., Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke DSM N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lonza Group (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cambrooke Therapeutics (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sichuan Kelun Pharmaceutical Co. Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Otsuka Pharmaceutical (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hormel Health Labs (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Perrigo Company (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hero Group (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Victus (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Entrocare Nutritional Solutions (U.K.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation